Traducción, adaptación y validación de la versión española del SarQoL: una escala de vida relacionada con la salud específica de sarcopenia
Loading...
Download
Official URL
Full text at PDC
Publication date
2021
Defense date
28/10/2020
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Complutense de Madrid
Citation
Abstract
La sarcopenia es un síndrome geriátrico caracterizado por un trastorno progresivo y generalizado de la morfología y la función del músculo esquelético que se asocia con un mayor riesgo de padecer resultados adversos de salud que incluyen caídas, fracturas, deterioro funcional y aumento de mortalidad. Todas estas consecuencias negativas de la sarcopenia se relacionan con una peor calidad de vida en las personas que lo padecen. En el 2015, se desarrolló y validó un cuestionario en francés específico para analizar la calidad de vida en pacientes con sarcopenia, el SarQoL®. Desde entonces, el SarQoL® ha sido adaptado y validado a diferentes idiomas...
Sarcopenia is a geriatric syndrome characterized by a progressive and generalized disorder of skeletal muscle morphology and function that is associated with an increased risk of adverse health outcomes, including falls, fractures, functional impairment and increased mortality. All these negative consequences of sarcopenia are associated with an impaired quality of life. In 2015, a disease-specific questionnaire intended to measure the quality of life in patients with sarcopenia, SarQoL®, was developed and validated in French. Since then, SarQoL® has been adapted and validated in different languages...
Sarcopenia is a geriatric syndrome characterized by a progressive and generalized disorder of skeletal muscle morphology and function that is associated with an increased risk of adverse health outcomes, including falls, fractures, functional impairment and increased mortality. All these negative consequences of sarcopenia are associated with an impaired quality of life. In 2015, a disease-specific questionnaire intended to measure the quality of life in patients with sarcopenia, SarQoL®, was developed and validated in French. Since then, SarQoL® has been adapted and validated in different languages...
Description
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Medicina, Departamento de Medicina, leída el 28-10-2020